InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Shao Weihui, 管理人员. Director active across 1 company, notably Genscript Biotech Corporation. In total, 4 filings have been logged. History available since 2 April 2026. The latest transaction was filed on 2 September 2026 (Sale). Regulator: HKEX. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Shao Weihui is an executive at Genscript Biotech Corporation. He is involved in managing operations and the strategic development of the company, which focuses on biotechnology. His role is essential for innovation and growth.